Shot developed by Defense Ministry's Institute for Biological Research still far from wider phase 3 trials; Moderna says its vaccine will not be ready before US election

Head of Institute for Biological Research tells Knesset committee that trials on locally made drug could begin in October, but phase three testing likely won't be until next year